Wikidata

(Q45187722)

English

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

scientific article published on 14 December 2004

In more languages

Statements

title
Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15599544
retrieved
10 December 2017
author name string
J B Schnog
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15599544
retrieved
10 December 2017
T Teerlink
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15599544
retrieved
10 December 2017
F P L van der Dijs
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15599544
retrieved
10 December 2017
A J Duits
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15599544
retrieved
10 December 2017
F A J Muskiet
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15599544
retrieved
10 December 2017
CURAMA Study Group
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15599544
retrieved
10 December 2017
publication date
14 December 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15599544
retrieved
10 December 2017
page(s)
282-286
1 reference
stated in
Europe PubMed Central
PubMed ID
15599544
retrieved
10 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45187722&oldid=2139245849"